LCM
ROIV icon

Laurion Capital Management’s Roivant Sciences ROIV Stock Holding History

Laurion Capital Management’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-13,397
Closed -$142K – 550
2024
Q2 		$142K Buy
+13,397
New +$147K ﹤0.01% 496
2024
Q1 		– Sell
-1,885,901
Closed -$21.2M – 614
2023
Q4 		$21.2M Buy
1,885,901
+850,454
+82% +$8.29M 0.18% 110
2023
Q3 		$12.1M Sell
1,035,447
-667,215
-39% -$7.54M 0.07% 187
2023
Q2 		$17.2M Buy
1,702,662
+660,041
+63% +$5.9M 0.1% 171
2023
Q1 		$7.69M Buy
+1,042,621
New +$8.59M 0.05% 218

Other funds holding ROIV

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PSC
Patient Square Capital Menlo Park, California $564M AUM 261.3% 1-Year Est. Return

Laurion Capital Management's ROIV Position: Q3 2024 in Review

Laurion Capital Management sold out of Roivant Sciences (ROIV) in Q3 2024, closing a stake of 13,397 shares — an estimated $142K sold.

Laurion Capital Management first reported a position in ROIV in Q1 2023 and held it in 5 quarters. The position peaked at $21.2M in Q4 2023. 293 funds tracked by Wall St. Rank hold ROIV as of Q3 2024.

  • Laurion Capital Management reported no remaining Roivant Sciences position as of Q3 2024 after selling out during the quarter.
  • Laurion Capital Management sold 13,397 Roivant Sciences shares in Q3 2024, an estimated $142K.
  • Laurion Capital Management first reported a position in Roivant Sciences in Q1 2023 and held it in 5 quarters.
  • Laurion Capital Management's Roivant Sciences position peaked at $21.2M in Q4 2023.
  • 293 funds tracked by Wall St. Rank held Roivant Sciences as of Q3 2024.

Based on Laurion Capital Management's 13F filing for Q3 2024, filed 14 Nov 2024.